India, the world’s second-biggest rice grower, may have a record harvest this year as increased planting offset drought in the east of the country. Production may total 100 million tonnes in the year ending June 2011, compared with 89.3 million tonnes a year ago, said Vijay Setia, president of All India Rice Exporters’ Association. Output was a record 99.2 million tonnes in the year ended June 30, 2009, according to the...

A Hamburg-based lab, Eurofins, has alleged high levels of pesticide residue in Indian rice, basmati and non basmati. This is likely to start a long-drawn legal battle and for the time being jeopardise around $300m in basmati exports alone to Europe. The first batch of legal correspondence from the grain traders, a precedent to formal legal action, will be exchanged with the Hamburg-based private testing firm, Eurofins and Dr Speck...

With Europe and Gulf countries, putting in place stringent safety norms for ensuring that pesticide residue in agricultural crops remain below prescribed limits, basmati (aromatic rice) Exporters from India have urged the Union agriculture ministry to ensure that farmers use less pesticide. Europe and Gulf nations are main export destinations for Indian basmati rice. In a letter to agriculture ministry, Vijay Setia, president, All India Rice Exporters’ Association has said that some...

The National Advisory Council's move to restrict universalisation of the PDS to the most disadvantaged districts may ultimately end up limiting its impact. RECENT weeks have seen rather contradictory statements on the challenge of ensuring food security and the set of feasible initiatives for managing the food economy. To start with, the National Advisory Council (NAC), which recognises the need for a universal public distribution system (PDS), and which was expected to...

Their ongoing negotiations remain shrouded in secrecy, but there are already reports that India and the European Union (EU) will have a free-trade agreement ready by the end of August, and that they will be putting signatures to it before the end of 2010. Yet it is a potential development that is causing more nervous chatter than joyous jitters here in India, where drug manufacturers in particular have raised concerns over...